Microplastics and Nanomaterials: Understanding Emerging Contaminants in Environmental Testing

🎤Matthew BolinoHow do the hidden carbohydrate structures on your favorite protein powders shape the gut microbiome? &nbsp;In this episode of Concentrating on Chromatography, Matthew Bolino, M.S., from the University of Nevada, Reno, breaks down his latest research on N‑glycans from common dietary proteins (whey, egg white, soy, and pea) and how their structural diversity influences microbial fermentation and short‑chain fatty acid production.Bolino explains what N‑glycans are, why they behave like fiber in the gut, and how his team isolates and characterizes them using ethanol washes, enzymatic release (PNGase F and gut‑derived endoglycosidases), and advanced MALDI‑TOF and HILIC‑QTOF workflows. &nbsp;He also discusses his 2025 work comparing synthetic versus bovine whey N‑glycomes and mapping N‑glycan profiles across dietary protein sources, revealing how glycan architecture can reshape community diversity in in vitro fecal fermentations.Geared toward undergraduate and early‑career analytical chemists, this conversation dives into practical mass spec trade‑offs (MALDI vs QTOF vs LC/GC), real‑world troubleshooting in glycomics labs, and how microbiome‑targeted therapeutics and “symbiotic” designs may emerge from pairing specific microbes with preferred glycan structures. &nbsp;Bolino closes with career advice on building biomolecular analysis skills, understanding instrumentation fundamentals, and entering the rapidly growing field of glycomics and microbiome research.<h3>Video Transcription</h3><h4>Introduction</h4>Glycomics has emerged as a rapidly developing field within biomolecular science, expanding our understanding of post-translational modifications beyond well-known processes such as phosphorylation. Among these modifications, protein glycosylation—the covalent attachment of carbohydrate structures to proteins—plays a critical role in biological function, molecular recognition, and cellular communication.This discussion focuses on N-glycans, a class of structurally complex carbohydrates linked to proteins, and their occurrence in common dietary protein sources such as whey, egg white, soy, and pea protein. Particular emphasis is placed on their structural diversity, analytical workflows, and emerging relevance in gut microbiome research.<h4>Fundamentals of N-Glycans</h4>N-glycans are oligosaccharide structures covalently attached to proteins via nitrogen atoms, typically at asparagine residues. They represent one of the two major classes of protein glycosylation, alongside O-glycans.These glycans are characterized by:<ul><li>High structural diversity, arising from variations in monosaccharide composition and linkage patterns</li><li>Large size, typically comprising 7–15 monosaccharide units</li><li>Complex branching architectures, leading to a vast number of possible configurations</li></ul>Common monosaccharide components include:<ul><li>Mannose</li><li>Galactose</li><li>N-acetylglucosamine</li><li>N-acetylgalactosamine</li><li>Sialic acids</li></ul>Unlike free carbohydrates present in foods (e.g., glucose, lactose), N-glycans are protein-bound, which significantly influences their biological behavior.<h4>Biological Function and Dietary Relevance</h4>N-glycans play multiple roles in biological systems, including:<ul><li>Modulation of protein stability</li><li>Regulation of protein trafficking and localization</li><li>Facilitation of cell–cell communication and immune recognition</li></ul>They are particularly abundant on membrane and surface proteins, where they contribute to molecular signaling processes.From a dietary perspective, N-glycans exhibit unique behavior. Due to their size and protein-bound nature, they are not readily digested in the upper gastrointestinal tract. Instead, they can reach the colon, where they may function analogously to dietary fiber, interacting with the gut microbiota.<h4>Research Motivation</h4>The investigation of N-glycans in dietary proteins was initially driven by interest in protein nutrition and supplementation, particularly in the context of muscle growth and protein quality. However, this focus expanded upon recognition of the importance of glycosylation in biological systems.The field of glycomics offers:<ul><li>Extensive structural variability, enabling diverse biological functions</li><li>Relevance in disease mechanisms, including cancer, where glycosylation patterns can influence immune evasion</li><li>Opportunities to explore diet–microbiome interactions</li></ul>This combination of nutritional, biochemical, and biomedical relevance makes N-glycan research particularly compelling.<h4>Experimental Workflow for N-Glycan Analysis</h4>The analysis of N-glycans requires a multi-step workflow due to their covalent attachment to proteins.<h5>1. Protein Purification</h5>Dietary protein samples often contain:<ul><li>Free sugars</li><li>Lipids</li><li>Other matrix components</li></ul>To isolate glycoproteins:<ul><li>Cold ethanol precipitation is used to remove free carbohydrates</li><li>Multiple washing steps ensure removal of residual sugars</li><li>A phenol–sulfuric acid assay is applied to confirm the absence of free sugars</li></ul><h5>2. Enzymatic Release of N-Glycans</h5>N-glycans are enzymatically cleaved from proteins using:<ul><li>PNGase F (Peptide-N-Glycosidase F)</li></ul>This enzyme:<ul><li>Specifically cleaves the glycan from the protein backbone</li><li>Preserves the intact glycan structure</li></ul>Alternative approaches using gut-derived enzymes are being explored to improve accessibility and yield.<h5>3. Glycan Purification and Labeling</h5>Following release:<ul><li>Glycans are purified from the protein matrix</li><li>Chemical labeling is performed (e.g., 2-AA or procainamide tagging)</li></ul>Labeling enhances:<ul><li>Detection sensitivity</li><li>Chromatographic behavior</li></ul><h5>4. Analytical Techniques</h5>Two primary analytical platforms are employed:<ul><li>MALDI-TOF MS<ul><li>High sensitivity</li><li>Broad structural coverage</li></ul></li><li>HILIC-LC-MS<ul><li>Improved reproducibility</li><li>Enhanced chromatographic separation</li></ul></li></ul>These approaches provide semi-quantitative data, where signal intensity reflects relative abundance rather than absolute concentration.<h4>Analytical Challenges</h4>Several challenges are associated with N-glycan analysis:<h5>Low Abundance</h5><ul><li>Dietary proteins typically contain only 1–2% glycan content by weight</li><li>This limits yield and complicates downstream applications</li></ul><h5>Sample Preparation Complexity</h5><ul><li>Extensive purification is required to eliminate free sugars</li><li>Contamination risks must be carefully managed</li></ul><h5>Instrumentation Trade-Offs</h5><ul><li>Different analytical platforms offer complementary advantages</li><li>No single technique provides complete structural and quantitative information</li></ul><h4>Differences Between Plant and Animal N-Glycans</h4>Comparative analysis reveals distinct differences in glycan composition:<h5>Plant-Derived Proteins (e.g., soy, pea)</h5><ul><li>Predominantly high-mannose structures</li><li>Lower monosaccharide diversity</li><li>Simpler glycan architectures</li></ul><h5>Animal-Derived Proteins (e.g., whey, egg white)</h5><ul><li>Greater structural complexity</li><li>Inclusion of diverse monosaccharides (e.g., sialic acids)</li><li>More elaborate branching patterns</li></ul>These differences have important implications for biological function and microbial interactions.<h4>Implications for Gut Microbiome Research</h4>N-glycans represent a potential class of prebiotic substrates that can influence gut microbiota composition and activity.Key findings suggest:<ul><li>Structural diversity of glycans affects microbial utilization patterns</li><li>More complex glycans may promote greater microbiome diversity</li><li>Specific glycan structures may selectively stimulate beneficial microbes</li></ul>This has led to growing interest in:<ul><li>Synbiotic strategies, combining microbes with preferred substrates</li><li>Tailored dietary interventions to enhance metabolic outputs, such as short-chain fatty acids</li></ul><h4>Methodological Considerations</h4>A critical insight from this work is the importance of understanding analytical trade-offs:<ul><li>MALDI-TOF MS provides broader detection of glycan structures</li><li>LC-MS approaches offer greater reproducibility</li></ul>No single technique is universally optimal; instead, method selection should be guided by the specific research question.<h4>Conclusion</h4>N-glycans in dietary proteins represent a complex and biologically significant class of biomolecules with implications spanning nutrition, microbiology, and disease research. Advances in analytical methodologies continue to improve our ability to characterize these structures, despite challenges related to low abundance and structural diversity.A deeper understanding of N-glycan composition and function may enable the development of targeted nutritional strategies and microbiome-based therapeutics, highlighting the growing importance of glycomics in modern life sciences.<blockquote>This text has been automatically transcribed from a video presentation using AI technology. It may contain inaccuracies and is not guaranteed to be 100% correct.</blockquote><blockquote><h4>Concentrating on Chromatography Podcast</h4>Dive into the frontiers of chromatography, mass spectrometry, and sample preparation with host David Oliva. Each episode features candid conversations with leading researchers, industry innovators, and passionate scientists who are shaping the future of analytical chemistry. From decoding PFAS detection challenges to exploring the latest in AI-assisted liquid chromatography, this show uncovers practical workflows, sustainability breakthroughs, and the real-world impact of separation science. Whether you’re a chromatographer, lab professional, or researcher you'll discover inspiring content!You can find Concentrating on Chromatography Podcast in podcast apps:<ul><li><a target="_blank" rel="noopener noreferrer" href="https://open.spotify.com/show/1wZg67rCjoGju4yhqxI3tL">Spotify</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podcasts.apple.com/tz/podcast/concentrating-on-chromatography/id1788429185">Apple podcast</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podscan.fm/podcasts/concentrating-on-chromatography">podscan</a></li></ul>and on <a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/@ChromatographyTalk/videos">YouTube channel</a></blockquote>

N‑Glycans, Whey Protein, and the Gut Microbiome: Mass Spec Insights with Matthew Bolino

<div><div><div>Our immune system is incredibly powerful: among other things, it can recognize and destroy cancer cells. But tumors can be just as effective at avoiding detection – they build “invisibility shields” to protect themselves from attack.</div></div><div>One breakthrough in cancer therapy has been immune checkpoint inhibitors (ICIs), drugs that reactivate immune T cells and help them fight tumors again. However, only about 20–50% of patients respond well to this treatment. Researchers are therefore seeking alternative therapeutic strategies. A small and well-known molecule called adenosine plays a key role in these efforts.When tumor cells are stressed or dying, they release ATP, which is normally a signal that something is wrong in the tissue. But in the tumor microenvironment, ATP gets rapidly broken down by two enzymes, CD39 and CD73. Released adenosine acts like a chemical “calm-down” signal, binds to immune cells (T cells, NK cells, and others), and tells them to slow down, reducing their ability to kill cancer cells. Targeting CD73 therefore represents a promising strategy for developing new cancer treatments.</div><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/UOCHB_Nove_latky_mohou_podporit_imunitni_system_v_boji_s_rakovinou_88c5e82cd5.jpeg" alt="IOCB Prague: Development of potent inhibitors to boost the immune system's ability to fight cancer" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_UOCHB_Nove_latky_mohou_podporit_imunitni_system_v_boji_s_rakovinou_88c5e82cd5.jpeg 245w," sizes="100vw" width="661" height="363">At IOCB Prague, interdisciplinary teams led by Jan Řezáč, Jan Konvalinka, and Michal Hocek used a newly developed high-throughput screening method to test over 5,000 compounds, identifying two ribonucleoside derivatives as promising CD73 inhibitors.The scientists then improved the compounds’ activity by carefully modifying the ribonucleoside scaffold with bulky (het)aryl groups. Further optimization improved the pharmacokinetic properties of these compounds, yielding inhibitors with low clearance, long half-life, high solubility, and strong selectivity over related enzymes such as CD39.In cellular experiments, the compounds reduced adenosine production in cancer cells, restored T cell activation, and showed no toxicity toward human fibroblasts. The most active compound showed a single-digit picomolar inhibition constant (Ki).These findings establish a strong foundation for further in vivo efficacy and combination studies, which will explore the therapeutic potential of this novel inhibitor class.<blockquote><h4>The Original article</h4><h4><a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acsptsci.5c00707">Potent Competitive Inhibitors of Ecto-5′-nucleotidase (CD73) based on 6-(Het)aryl-7-deazapurine Ribonucleoside 5′-O-Bisphosphonates</a></h4>Ugnė Šinkevičiu̅tė, Magdalena Šímová, Radek Staník, Lenka Poštová Slavětínská, Kristýna Blažková, Pavel Šácha, Martin Lepšík, Jan Řezáč, Jan Konvalinka, Tereza Ormsby, Michal Tichý, Michal HocekACS Pharmacol. Transl. Sci. 2026, 9, 1, 191–213<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acsptsci.5c00707">https://pubs.acs.org/doi/10.1021/acsptsci.5c00707</a><h6>licensed under <a target="_blank" rel="noopener noreferrer" href="https://creativecommons.org/licenses/by/4.0/">CC-BY 4.0</a></h6></blockquote><h4>Abstract</h4>CD73 generates immunosuppressive adenosine in the tumor microenvironment and is a promising target for cancer immunotherapy. We have designed and systematically studied diverse 2-substituted 7-deazapurine ribonucleoside 5′-O-bisphosphonates bearing a variety of (het)aryl groups at position 6 and discovered their highly potent and selective CD73 inhibition activity. The most active compounds (with single-digit picomolar Ki) contained bicyclic (het)aryl groups at position 6 in combination with chlorine at position 2. Further optimization of pharmacokinetic properties identified inhibitors with low clearance, long half-life, high solubility, and excellent selectivity over CD39 and NTPDase3. They effectively suppressed adenosine formation in MDA-MB-231 cells, rescued CD8+ T cell activation, and were nontoxic to human fibroblasts. Overall, their profile compares favorably with AB680, a CD73 inhibitor currently in phase I/II clinical trials.</div>

Development of potent inhibitors to boost the immune system's ability to fight cancer

Article

Video

Scientists

Environment

Scientific article

Interview

Science and research

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. 

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Metrohm

Agilent Technologies

Bruker

Phenomenex

C&EN

SCIEX

Waters Corporation

<h4>European Free Educational Webinar Series</h4>
Let&#39;s go back to the basics of Chromatography, Mass Spectrometry, Data Analysis and Trouble-shooting: understanding the importance of the basics will enable you to be more effective in your daily laboratory life.
<h4>EPISODE 4</h4>
Basics of Liquid Chromatography
What will you learn?
<ul>
<li>LC System Components: Pumps and Injectors</li>
<li>LC Detectors: Which one is right for your Application?</li>
</ul>
<blockquote>
Prezenter: Andrea Gheduzzi (Principal LC Market Dev. Manager, EMEA, Waters Corporation)
</blockquote>
<blockquote>
Andrea has spent more than 30 years in the chromatography field. Across his career he had various roles, service engineer, chromatography lab position, and technical application support manager. He has mainly been dealing with pharma accounts, also supporting LC method development activities using DoE/QbD approaches. In his role as Pharma Business Development Manager at Waters he has further expanded his expertise in AQbD and related applications.
</blockquote>
<blockquote>
Prezenter: Arjan Timmerman (Pharma Market Development Manager EMEA, Waters Corporation)
</blockquote>
<blockquote>
Arjan Timmerman is a market development manager at Waters working in EMEA. Prior to joining Waters in 2014 he worked for 17 years as an Analytical Scientist in the Small Molecule Pharmaceutical industry in various Chemical and Pharmaceutical late-stage development labs.
</blockquote>
<blockquote>
Since 2023 he became QA/QC market development manager for EMEA working in a dedicated team and focuses on Pharmaceutical workflows, AQbD, Impurities, LC Chromatography and Compliance.
</blockquote>
<h4>What&#39;s next?</h4>
Full Webinar Series Episodes List is available <a href="https://event.on24.com/wcc/r/4551012/F69479929A905500D8B21508527807E5/5385652">here</a>
Back to Basics - Sample Preparation: Theory and Overview
<ul>
<li>Tuesday, May 07, 2024, 11:00 AM CEST</li>
</ul>
Back to Basics - Sample Preparation: Tips &amp; Tricks to make it simple
<ul>
<li>Wednesday, June 05, 2024, 11:00 AM CEST</li>
</ul>
Back to Basics - Theory of Liquid Chromatography
<ul>
<li>Wednesday, July 03, 2024, 11:00 AM CEST</li>
</ul>
Back to Basics - Basics of Liquid Chromatography
<ul>
<li>Tuesday, September 10, 2024, 11:00 AM CEST</li>
</ul>
Back to Basics - Analytical Method Development
<ul>
<li>Wednesday, October 02, 2024, 11:00 AM CEST</li>
</ul>
Back to Basics - The importance of Compliance
<ul>
<li>Tuesday, October 22, 2024, 11:00 AM CEST</li>
</ul>
Back to Basics - Introduction to Mass Spectrometry
<ul>
<li>Wednesday, November 13, 2024, 11:00 AM CET</li>
</ul>
Back to Basics - Troubleshooting your LC and MS Systems
<ul>
<li>Tuesday, December 10, 2024, 11:00 AM CET</li>
</ul>
Not sure to be able to attend live sessions?
Register today and watch the webinars on-demand

Waters Corporation: Back to Bacisc Free Educational Webinar Serries

Basics of Liquid Chromatography

Intro to LC system components: pumps, injectors, and detectors.

<h3>PFAS and us: The science</h3>
Driving change for a healthier world
Webinar series
<h4>Enrich your understanding of PFAS chemicals and their impact</h4>
Stay on the leading edge of all things PFAS with this enlightening monthly webinar series on testing workflows and cutting-edge technology that will demystify these “forever chemicals”.
Each month, in these 30-minute sessions, industry thought leaders unite to share the current state of PFAS testing and the far-reaching impact that PFAS have on human health and the environment. Build on your current knowledge of testing methodologies and research techniques that will help you develop your own innovative strategies for precise identification and quantitation. Make a lasting impact and join us for these conversations.
<h4>This Webinar:</h4>
September 11, 2024 10:00 a.m. PT/ 1:00 p.m. ET - Analysis of ultra short-chain PFCAs to better understand environmental sources and fate
<blockquote>
Presenter: Cora J. Young (Associate Professor, Department of Chemistry, York University)
</blockquote>
<h4>Other Webinars from the Series:</h4>
April 10, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3865">Examining the exogenous: PFAS and beyond</a>
<blockquote>
Presenter: Andrew Patterson (Vice President, Innovation and Development, Eurofins Environmental Testing America)
</blockquote>
May 8, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3865">Rapid PFAS testing with no compromises: direct-inject analysis</a>
<blockquote>
Presenter: Jamie Fox (PFAS Technical Program Manager, Enthalpy Analytical)
</blockquote>
June 12, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3867">Assessment of advanced analytical instruments to reach required limits of quantitation for PFAS in foods</a>
<blockquote>
Presenter: Susan Genualdi, PhD (Research Chemist, FDA, Center for Food Safety and Applied Nutrition, Office of Regulatory Science)
</blockquote>
July 17, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3868">Detecting and identifying known and novel per/polyfluoroalkyl substances (PFAS) in a marine apex predator</a>
<blockquote>
Presenter: Carrie McDonough (Assistant Professor, Chemistry, Carnegie Mellon University)
</blockquote>
August 14, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3869">Whole blood microsampling methods for PFAS exposure biomonitoring</a>
<blockquote>
Presenter: Andrew J. Morris, PhD (Professor, University of Arkansas for Medical Sciences, Research Career Scientist, Central Arkansas Veterans Affairs Healthcare System)
</blockquote>

Analysis of ultra short-chain PFCAs to better understand environmental sources and fate

Analysis of ultra short-chain PFCAs

Who Should Attend:
Anyone new to SPE who wants to get familiar with the basics of SPE method development. Anyone who has a basic understanding of SPE and would like to learn how to improve their extractions. 
Key Learning Points:
<ul>
<li>Understand how to develop SPE methods from start to finish.</li>
<li>Receive general methods to use as starting points.</li>
<li>Learn when and how to optimize SPE methods, and discover new tips and tricks to make SPE method development easier.</li>
</ul>
<blockquote>
Presenter: Koen Askamp (Technical Specialist, Phenomenex)
</blockquote>
<blockquote>
Koen Askamp is a Technical Specialist at Phenomenex. He was awarded his BSc and MSc degrees in Molecular Life Sciences at Wageningen University in the Netherlands and joined Phenomenex in 2020 as Technical Sales Consultant. Koen became part of Phenomenex’s global technical support team in 2022 and assists laboratories in training chromatographers and developing analytical methods. 
</blockquote>

Phenomenex: Solid Phase Extraction Method Development

Solid Phase Extraction Method Development

Learn when and how to optimize SPE methods, and discover new tips and tricks to make SPE method development easier.

Event Overview:
<ul>
<li>Principle of Chirality
</li>
<li>Chiral Stationary Phases (CSP)
</li>
<li>Polysaccharide CSPs and their Chiral Retention Mechanisms
</li>
<li>Chiral Method Development: Separation Modes and Screening Protocol
</li>
<li>SFC Chiral Method Development
</li>
<li>Chiral Method Optimization: Case Study
</li>
</ul>
Who Should Attend:
<ul>
<li>Any LC users who would like to understand how chiral separations work and how to apply the principles of chiral theory in developing an analytical method for separation of enantiomers.
</li>
<li>Any analyst who wishes to learn the basics of chiral theory.
</li>
<li>Any academic or pharmaceutical scientists who need to develop a method for separation and characterization of chiral compounds.
</li>
</ul>
Key Learning Points:
<ul>
<li>Learn what chiral compounds are and how they are separated using LC and what a chiral stationary phase (CSP) is and the different types there are
</li>
<li>Understand the three critical components of Polysaccharide CSPs and review the difference between coated and immobilized CSPs and how they are applied in different analytical contexts
</li>
<li>Learn how to approach a chiral screen using different separation modes.
</li>
</ul>
<blockquote>
Presenter: Laura K Ward (Technical Specialist, Phenomenex)
</blockquote>
<blockquote>
Laura Ward is a Technical Specialist for the Asia-Pacific region with Phenomenex, located in New Zealand. She completed an Honours thesis in the field of Geochemistry at the University of Sydney, Australia where she discovered a love for Analytical Chemistry. Following her academic pursuits, Laura joined Phenomenex Australia as a Technical Sales Consultant where she supported various industries and laboratories. After 5 years and a move to New Zealand, she has joined the Phenomenex Technical Team where she supports scientists globally with their method development, troubleshooting and application support. In her spare time Laura enjoys being outdoors in the New Zealand countryside and cooking from scratch, most recently venturing into cheesemaking!
</blockquote>

Phenomenex: LC Chiral Theory and Method Development

LC Chiral Theory and Method Development

Learn what chiral compounds are and how they are separated using LC and what a chiral stationary phase (CSP) is and the different types there are.

With the timsTOF Pro, powered by the PASEF® acquisition modes, Bruker has largely contributed to take proteomics analysis to a new dimension, by removing the need to compromise speed for sensitivity or selectivity, while reaching unprecedented levels of robustness.
Introduced @ ASMS 2024, the timsTOF Ultra 2 is the pinnacle of timsTOF evolution, combining ultimate sensitivity, speed, selectivity and dynamic range with the field-proven legendary timsTOF robustness. During this live from the lab, you will witness through real-life examples how sensitive and versatile the timsTOF Ultra 2 can be.

Bruker: Taking 4D-Proteomics™ to the routinely exceptional with the timsTOF Ultra 2j

Taking 4D-Proteomics™ to the routinely exceptional with the timsTOF Ultra 2

Through real-life examples how sensitive and versatile the timsTOF Ultra 2 can be.

Taking 4D-Proteomics™ to the routinely exceptional

Increase process understanding and shorten time to market of therapeutics using inline variable pathlength spectroscopy. In this webinar we will discuss how the FlowVPX System can be integrated in-line, at different steps in a downstream process, to help reduce cycle time and save money by monitoring and controlling CQA (concentration).
Key Learning Objectives:
<ul>
<li>Overview of slope spectroscopy and how it differs from traditional fixed-pl uv-vis techniques and instruments.</li>
<li>Learning how the FlowVPX System can help increase process understanding, strengthen process control with high quality concentration results, and eliminate hold-up times for increased resource utilization.</li>
<li>Analyzing downstream applications for chromatography, ultra-filtration/diafiltration, and formulation.</li>
</ul>
Who Should Attend:
<ul>
<li>MSAT Director and Scientists</li>
<li>Process Development Directors and Scientists</li>
<li>Process Analytical Technology Directors and Scientists</li>
<li>Biopharma Organizations</li>
<li>Downstream Purification for mRNA, pDNA, mABs, fusion proteins, and peptides</li>
</ul>
<blockquote>
Presenter: Jigar Patel (Sr. Bioprocess Applications Engineer, Repligen)
</blockquote>
<blockquote>
Presenter: Punya Bhat (Bio-Analytics Applications Specialist, Repligen)
</blockquote>
<blockquote>
Moderator: Melissa O&#39;Meara (Forensic Science Consultant, C&amp;EN Media Group)
</blockquote>

C&EN: VMaximize Downstream Control and Efficiency with In-line Concentration Measurement

Maximize Downstream Control and Efficiency with In-line Concentration Measurement

In this webinar we will discuss how the FlowVPX System can be integrated in-line, at different steps in a downstream process.

In-line Concentration Measurement

Automatic titration plays a crucial role in ensuring precise and consistent results in various industry and research sectors, directly impacting the quality and safety of products we use daily. Despite the automation of the titration process itself, many manual steps still require an analyst&#39;s full-time attention. By optimizing titration procedures and using advanced instruments and accessories, it is possible to automate auxiliary tasks such as pipetting, diluting, and adding reagents. This optimization also enables the system to make decisions, such as whether to proceed with an analysis or take specific actions based on the results.
In this webinar, Monica Laurel, Analytical Manager at Dow Chemical, will share success stories of titration methodology optimization carried out by her and her team across various Dow Chemical units during her 20-year career. Eduardo Simões, Product Specialist for Titration at Metrohm USA, will demonstrate how automated systems can systematically reduce human error, ensure compliance with laboratory safety regulations, and enhance the accuracy and reproducibility of results.
Don&#39;t miss the live Q&amp;A at the end, where Monica and Eduardo will answer all your questions.
Please plan to attend if you:
<ul>
<li>Want to learn about titration procedure optimization</li>
<li>Are interested in reducing exposure to chemicals during titration analysis</li>
<li>Would like to understand how advanced software functions can monitor results and help with decision making</li>
<li>Are interested in improving the consistency of your titration results</li>
</ul>
Key Learning Points
<ul>
<li>Understand different ways to optimize your current titration methodology</li>
<li>Learn how a sample robot can help save analyst time by automating manual steps</li>
<li>Learn advanced software functions for better programming and monitoring data</li>
</ul>
<blockquote>
Presenter: Monica Laurel (Analytical Manager, Dow Chemical)
</blockquote>
<blockquote>
Monica Laurel is a Research Scientist with DOW Chemical in Freeport, Texas. She received her BS in Chemistry from the University of Texas at Austin. Monica joined Union Carbide in St. Charles, LA in 1995 as a process chemist. In 2004 she moved back to Texas and joined the Analytical Sciences group at DOW Chemical and began work in the Inorganic Lab focusing on titration technology. She has 20 years experience in numerous titration and Karl Fischer methods and techniques where she has worked to improve and automate titrations for implementing in DOW’s quality labs.
</blockquote>
<blockquote>
Presenter: Eduardo Simões (Titration Product Specialist, Metrohm USA)
</blockquote>
<blockquote>
Eduardo Simoes, MSc is the Titration Product Specialist at Metrohm USA in Riverview, Florida. He received his bachelor and masters in analytical chemistry at the University of Campinas, Brazil. Over the last 21 years with Metrohm, he specialized in potentiometry and electroanalysis, gaining extensive field experience in applications and instrument installations, technical support &amp; training.
</blockquote>

Metrohm: Real-World Titration Optimization: Advanced Techniques for Improved Results

Real-World Titration Optimization: Advanced Techniques for Improved Results

We will share success stories of titration methodology optimization and demonstrate how automated systems can systematically reduce human error.

Titration: Advanced Techniques for Improved Results

<div class="summary-section section">This webinar will introduce liquid chromatography and provide a comprehensive overview of an HPLC system, helping new users understand the purpose of each component. It will also explore some common chromatographic terms, what they mean to the separation, and how understanding these terms can help analysts make better decisions. Finally, we will discuss the attributes of chromatographic columns and how they impact the separation process.<h5>Key Learnings:</h5>1. HPLC system overview2. Key chromatographic terms3. Chromatography overview4. Understanding the chromatographic column&nbsp;<div style="clear:both;">Who should attend: Analysts who are brand new to HPLC or those who need a strong understanding of the principal concepts of HPLC.</div><div style="clear:both;">&nbsp;</div><blockquote><div>Presenter: Maureen DeLoffi (Senior Product Manager, Waters Corporation)</div><div> Maureen DeLoffi is a Senior Product Manager at Waters Corporation, where she manages the small molecule portfolio of Analytical HPLC columns. Prior to her Product Manager role, she spent over 12 years as a scientist in the Column Technology Development Lab at Waters. She holds a bachelor’s degree in Mechanical Engineering from the University of New Hampshire.</div></blockquote></div>

Waters Corporation: Fundamentals of HPLC Separations for Small Molecule Analyses

Fundamentals of HPLC Separations for Small Molecule Analyses

This webinar will introduce liquid chromatography and provide a comprehensive overview of an HPLC system.

<h3>Session #1 - Advancements in Targeted Quantitation of PFAS</h3>We are thrilled to invite you to our upcoming webinar focused on enhancing laboratory efficiency and accuracy in PFAS analysis. Join us to explore innovative solutions that streamline processes and improve detection capabilities.1. Harnessing the Power of Mass Spectrometry and Automation to Reduce Sample Size, Sample Preparation Time and Increase Laboratory Efficiency of PFAS Analysis for EPA 1633<ul><li>Presented by Kari Organtini</li></ul>EPA Method 1633 is widely used for analyzing PFAS in non-potable water, soils, biosolids, and tissues. This presentation will show how advanced mass spectrometry and automation can significantly reduce sample size, cut down preparation time, and boost overall laboratory efficiency.2. Identification of short chain per and polyfluorinated alkyl substances (PFAS) using ion ratios with low mass product ions<ul><li>Presented by Stuart Adams</li></ul>As long-chain PFAS are replaced by short and ultrashort-chain alternatives, their detection becomes more challenging. This talk will cover how modified tandem quadrupole mass spectrometry enhances sensitivity, enabling the identification of these difficult-to-detect PFAS compounds using low-mass product ions.3. Evaluation of DESI mounted on Q-TOF and TQ mass spectrometers to image PFAS compounds in different matrices<ul><li>Presented by Emmanuelle Claude</li></ul>Direct analysis with minimum sample preparation as well spatial dimension of PFAS in samples can add simplicity and localization information, to complement state of the art detection and quantification by UHPLC-MRM analysis. Results are presented to evaluate the level of detection of few tens of PFAS compounds that were spotted on porcine liver tissue section, after updating the DESI imaging workflow to minimize external contamination. Several mass spectrometers such as discovery workflow in full scan TOF mode on the MRT and Cyclic mass spectrometers as well as targeted workflow using MRM acquisition mode on the DESI XS Xevo TQ Absolute MS were compared. Finally the benefit of ion mobility separation for the MSI analysis of PFAS is described. 61% and 55% of the PFAS compounds were detected as low as 10 ng/mL spotted on tissue when analyzed by negative mode DESI in discovery full scan MS acquisition mode. The targeted MRM workflow is the most sensitive system with 77% of the PFAS compounds detected as low as 10 ng/mL spotted on tissue.Join us to learn how these technologies are transforming PFAS analysis, helping laboratories meet the growing demand for more efficient and accurate testing.<blockquote>Presenter: Dr. Stuart Adams (Principal Scientist, Market Development, Food and Environmental Applications, Europe, Waters Corporation)Stuart has been developing methods for the determination of contaminants in food and the environment for over 17 years and has been with Waters Corporation since 2018. Stuart's previous role was as a senior analytical chemist at Fera (the UK’s National Reference Laboratory) and moved to Waters to focus on application development in the European region. He now serves as the attached scientist to the European Market Development team responsible for the food and environmental application areas. In his role, he works with customers to understand their analytical challenges and helps address them with Waters technologies.Presenter: Kari Organtini, Ph.D. (Principal Scientist, Food &amp; Environmental, Waters Corporation)Kari Organtini is a senior scientist at WatersCorporation and has been with the company for five years. She received her PhD from Penn State University in 2015 studying the occurrence of dioxins and furans in fire debris and their implications to first responder health. At Waters, Kari is part of the food and environmental applications team. Kari has developed applications using both LC and GC techniques for a variety of applications ranging from pesticides to persistent organic pollutants during her career. She is currently the scientific lead for developing PFAS applications at Waters.Presenter: Emanuelle Claude (Consulting Scientist D&amp;C Imaging, Waters Corporation)Miss Emmanuelle Claude (Master in Fine Chemistry and Business and M.Phil in spectroscopy analysis in organic chemistry and biology) is currently a Consulting scientist in the Scientific Operations Department, Wilmslow, UK.She started at Waters Corporation in October 2000 as an Application Chemist in the Proteomics and Genomics Marketing group, developing automated Peptide Mass Fingerprint (PMF) MS methods using a MALDI-TOF mass spectrometer.Over the years she developed several methods in the proteomics analytical space using MALDI TOF and naturally moved in starting the development of Mass Spectrometry Imaging (MSI) at Waters corporation over 15 years ago.She has been involved with hardware and software R&amp;D to ensure that the solutions are fit-for-purpose for the MSI community and beyond. She has worked extensively with the main MSI leaders in Europe and the US such as Prof Heeren in the Netherlands, Prof Clench, Prof Takats and Bunch in the UK and Prof Caprioli in the US. She has been a Principal Scientist since 2014 and became a Consulting scientist in 2021 and is part of the MS imaging application team at Waters where data are generated for collaborations and marketing activities (i.e. application literature, customer presentation, papers, posters...), hardware and software requirements are defined for the R&amp;D teams. The team evaluates and develops new applications &amp; methods for imaging by both MALDI and DESI mass spectrometry, support sales with customers visit and demonstration laboratory worldwide.Presenter: Ken Rosnack (Principal Market Development Manager, Waters Corporation)Ken Rosnack is a Principal Market Development Manager in the Testing &amp; Lab Services Group for Waters Corporation. His primary focus is within regulated and routine LC-MS/MS environmental market where he is responsible for world-wide strategy implementation and performance. He maintains collaborations within regulatory agencies as well as with global industrial partners. Over his career, Ken has been primary author on numerous publications, been an invited speaker multi-nationally, and has presented at many conferences. He has been involved with MS for the past 40 years.</blockquote>

Waters Corporation: Advancements in Targeted Quantitation of PFAS

Advancements in Targeted Quantitation of PFAS

Learn how technologies are transforming PFAS analysis, helping laboratories meet the growing demand for more efficient and accurate testing.

We start the LC Beginner webinar series with an overview of basic terms relevant to liquid chromatography.&nbsp;<blockquote>Presenter: Laura Montis (Product Specialist Liquid Phase Separations, Agilent)Laura began her carrier in the Liquid Chromatography over 15 years ago. After experiencing the pharmaceutical world in an analytical development lab, she went on to work with preparative chromatography and gained experience with Supercritical Fluid Chromatography prior to moving onto special HPLC applications, like 2DLC and Online LC.Throughout her career, Laura has held several positions, including application chemist, trainer, sales specialist, and marketing business development. She is currently Product Specialist for liquid phase chromatography systems within the International Distributor Organization in EMEA at Agilent Technologies.Laura studied analytical chemistry and holds a master’s degree from University of Lyon in France.</blockquote>

Agilent Technologies: HPLC Beginner Webinar Series

Liquid Chromatography Fundamentals

We start the LC Beginner webinar series with an overview of basic terms relevant to liquid chromatography. 